Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04958122 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cefixime Clinical Trial

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv9
  2. Primary completion date: Jan 1, 2025 to Jan 1, 2027
    • Study completion date: Jun 30, 2025 to Jun 30, 2027
    • Site contact updated
    v8
  3. Re-verified, no change to tracked fieldsv7
  4. Primary completion date: Jul 1, 2024 to Jan 1, 2025
    • Study completion date: Mar 1, 2025 to Jun 30, 2025
    v6
  5. 2 versions Re-verified since Nov 27, 2023, no change to tracked fieldsv4-v5
Show 2 earlier versionsHide 2 earlier versions
  1. Primary completion date: Jun 2024 to Jul 1, 2024
    • Study completion date: Jun 2025 to Mar 1, 2025
    v3
  2. Primary endpoint revised
    • Study description revised
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the efficacy of cefixime compared to benzathine penicillin G in the treatment of syphilis.
Trial Details
NCT Number NCT04958122
Lead Sponsor University of Southern California
Collaborators: AIDS Healthcare Foundation, Universidad Peruana Cayetano Heredia
Conditions
(from sponsor)		 Syphilis, Human Immunodeficiency Virus
Related terms Acquired Immunodeficiency Syndrome, Syphilis, Treponemal Infections
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov